Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
ALL
Fred Hutchinson Cancer CenterCell therapyPhase 2/3Active
BBB
74/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 64/ 100
- Competitive Position
- 95/ 100
Competitive context
252 Active assets in the ALL cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Gm-Csf Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 | BBB |
Equine Atg Instituto Nacional de Cancer, Brazil | Phase 3 | BBB |
THIOGUANINE ANHYDROUS St. Jude Children's Research Hospital | Phase 4 | BBB |
VINCRISTINE SULFATE Children's Oncology Group | Phase 3 | BB |
ASPARAGINASE Centre Hospitalier Universitaire de Nice | Phase 4 | BB |
View all 50 →
Same molecule, other indications
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →